|
Profiling EGFR and Her2 in Breast Cancer using Multiplex Tissue Immunostaining
|
1R43CA123994-01A2
|
$117,930
|
$117,930
|
JAMES, WILLIAM
|
20/20 GENESYSTEMS, INC.
|
|
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
|
1R44CA124032-01A1
|
$101,130
|
$101,130
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
Aerosol Therapy for Lung Cancer
|
5R44CA096409-03
|
$371,115
|
$371,115
|
Hansen, Brian
|
AEROPHASE, INC.
|
|
Tumor Microenvironment: Progression, Therapy and Prevention
|
1R13CA128588-01
|
$10,000
|
$2,500
|
DeClerck, Yves
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
3U10CA021661-32S1
|
$300,000
|
$120,000
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
5U10CA021661-32
|
$8,875,198
|
$3,550,079
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
5U10CA037422-20
|
$1,483,085
|
$296,617
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group-Statistical Center
|
5U10CA032115-26
|
$1,038,338
|
$415,335
|
Sadek, Ramses
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
QUALITY RESEARCH IN RADIATION ONCOLOGY: ACR PCS
|
5R01CA065435-09
|
$778,031
|
$272,311
|
WILSON, JESSE
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Drug binding microprotein domains for targeted delivery of cytotoxic drugs
|
1R43CA128137-01
|
$108,284
|
$108,284
|
Schellenberger, Volker
|
AMUNIX, INC.
|
|
Drug Delivery Carriers Targeted to Breast Tumor by Fusion Phage Proteins
|
1R01CA125063-01
|
$411,927
|
$411,927
|
PETRENKO, VALERY
|
AUBURN UNIVERSITY AT AUBURN
|
|
Calpain Inhibitors for Cancer Related Neuropathies
|
1R43CA121653-01A1
|
$187,907
|
$187,907
|
WEBB, ROBERT
|
AXONA, INC.
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-18
|
$480,000
|
$211,200
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
NSABP Participating Sites
|
5U10CA118735-02
|
$66,456
|
$53,165
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
RNAi-Based Therapy of Hepatocellular Carcinoma
|
5R01CA109574-03
|
$224,720
|
$224,720
|
LI, KAIYI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cytokine Expression in LCH and Therapeutic Response
|
5R21CA114981-02
|
$232,676
|
$232,676
|
MCCLAIN, KENNETH
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
1P30CA125123-01
|
$1,500,000
|
$30,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-01S1
|
$111,700
|
$2,234
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer
|
3P50CA058183-13S1
|
$153,479
|
$38,370
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer
|
5P50CA058183-13
|
$2,612,827
|
$653,207
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Improving the Efficacy of Dendritic Cell Vaccines
|
5P01CA084512-06
|
$978,697
|
$293,609
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
Generic Fluorescent HTS Assay for Kinases and ATPases
|
5R44CA110535-03
|
$257,753
|
$257,753
|
Lowery, Robert
|
BELLBROOK LABS, LLC
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-24S1
|
$80,000
|
$32,000
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-24
|
$391,000
|
$156,400
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Eastern Cooperative Oncology Group
|
2U10CA080775-09
|
$128,678
|
$128,678
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Enhanced RF Tumor Ablation with Liposomal Chemotherapy
|
5R01CA112533-04
|
$369,193
|
$369,193
|
GOLDBERG, S
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Generation of Antiangiogenic Activity for Cancer Treat.
|
5R01CA098948-05
|
$270,081
|
$270,081
|
SUKHATME, VIKAS
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Circulating Tumor Cells in Non-Small Cell Lung Cancer
|
1R01CA125653-01A1
|
$332,207
|
$332,207
|
Nieva, Jorge
|
BILLINGS CLINIC FOUNDATION
|
|
SBIR TOPIC 241 - TARGETED NANOPARTICLES FOR PROSTATE CANCER THERAPY
|
N43CO700060-000
|
$150,000
|
$150,000
|
HRKACH, JEFFREY
|
BIND BIOSCIENCES, INC.
|
|
Long Acting VEGF BInding Proteins for Treating Cancer
|
5R44CA099217-03
|
$335,148
|
$167,574
|
Cox, George
|
BOLDER BIOTECHNOLOGY, INC.
|
|
Analysis of AND-34 in human breast cancer
|
5R01CA114094-03
|
$229,749
|
$114,875
|
LERNER, ADAM
|
BOSTON MEDICAL CENTER
|
|
Optical Spectroscopy for Management of Cancer Treatment
|
5U54CA104677-05
|
$1,087,460
|
$543,730
|
BIGIO, IRVING
|
BOSTON UNIVERSITY
|
|
Hepatic Metabolism of Anti-cancer Drugs
|
3R01CA049248-18S1
|
$49,584
|
$49,584
|
WAXMAN, DAVID
|
BOSTON UNIVERSITY
|
|
Hepatic Metabolism of Anti-cancer Drugs
|
5R01CA049248-18
|
$275,637
|
$275,637
|
WAXMAN, DAVID
|
BOSTON UNIVERSITY
|
|
Ras Oncoprotein-Targeted Therapy for Cancer
|
3R01CA112102-03S1
|
$49,449
|
$49,449
|
Faller, Douglas
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Ras Oncoprotein-Targeted Therapy for Cancer
|
5R01CA112102-03
|
$302,435
|
$302,435
|
Faller, Douglas
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Modification of tamoxifen effectiveness by gene polymorphisms and other drugs
|
5R01CA118708-02
|
$234,985
|
$117,493
|
LASH, TIMOTHY
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
The fuel sensing enzyme AMPK in the pathogenesis of prostate cancer
|
5R01CA118918-02
|
$224,058
|
$224,058
|
Luo, Zhijun
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Heat shock proteins in cancer and signaling
|
5R01CA081244-09
|
$343,115
|
$68,623
|
SHERMAN, MICHAEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Curcumin suppression of head and neck cancer
|
1R21CA116826-01A2
|
$123,600
|
$61,800
|
WANG, MARILENE
|
BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
|
|
Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE
|
3P50CA105009-04S1
|
$87,500
|
$17,500
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE
|
5P50CA105009-04
|
$2,278,757
|
$455,751
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Multicenter clinical trials for TSC & related disorders
|
5R01CA107164-03
|
$332,328
|
$332,328
|
DABORA, SANDRA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
SPORE in Skin Cancer
|
3P50CA093683-05S2
|
$512,285
|
$102,457
|
KUPPER, THOMAS
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
A Pilot Trial of Oral Melatonin Supplementation in Breast Cancer Survivors
|
5R03CA123597-02
|
$84,574
|
$84,574
|
SCHERNHAMMER, EVA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Biomarkers and Therapeutic Targets in Pancreatic Cancer
|
5R01CA114103-03
|
$287,037
|
$114,815
|
WHANG, EDWARD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Addressing Fertility Issues with Female Cancer Patients
|
5R21CA114385-02
|
$175,312
|
$175,312
|
ALLEN, SUSAN
|
BROWN UNIVERSITY
|
|
Controlled Functionalization of Composite Magnetic Nanoparticles for Targeted Del
|
1R21CA128529-01
|
$165,496
|
$165,496
|
Sun, Shouheng
|
BROWN UNIVERSITY
|
|
Therapeutic Modulation of Breast Cancer Oncogenes
|
5R01CA036773-25
|
$321,908
|
$321,908
|
Benz, Christopher
|
BUCK INSTITUTE FOR AGE RESEARCH
|
|
Cellular Pharmacology of Rapamycin
|
5R01CA076193-10
|
$318,589
|
$318,589
|
CHIANG, GARY
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
Total relevant funding to Chemotherapy for this search: $520,650,833
|